Histogen Inc. Forms 3, 4 and 5: Preferred Stock
Statements of beneficial ownership filed with the SEC by officers, directors and 10% owners: 95 rows, 95 shown. Transaction codes are the SEC's. Shares and prices are split-adjusted; the as-filed figure is underneath.
- 2013-07-30: Reporting owner Spada Alfred P.; Form 4; Security Series A Preferred Stock; Transaction C Conversion of derivative security.
- 2013-07-30: Reporting owner Aberdare Ventures III LP | Aberdare GP III, L.L.C. | Aberdare Partners III LP; Form 4; Security Series A Preferred Stock; Transaction C Conversion of derivative security.
- 2013-07-30: Reporting owner Aberdare Ventures III LP | Aberdare GP III, L.L.C. | Aberdare Partners III LP; Form 4; Security Series B Preferred Stock; Transaction C Conversion of derivative security.
- 2013-07-30: Reporting owner Aberdare Ventures III LP | Aberdare GP III, L.L.C. | Aberdare Partners III LP; Form 4; Security Warrant to Purchase Series A Preferred Stock; Transaction C Conversion of derivative security.
| Transaction date | Reporting owner | Form | Security | Transaction | Shares | Price | Price that day | Filing |
|---|---|---|---|---|---|---|---|---|
| 2013-07-30 | Spada Alfred P. Officer (SVP, R&D and CSO) | 4 | Series A Preferred Stock Derivative · Indirect · See footnote | C Conversion of derivative security | −363,927 0 owned after | no price filed | 2013-08-01 | |
| 2013-07-30 | Aberdare Ventures III LP | Aberdare GP III, L.L.C. | Aberdare Partners III LP 10% Owner | 10% Owner | 10% Owner | 4 | Series A Preferred Stock Derivative · Indirect · By Aberdare Ventures III, L.P. | C Conversion of derivative security | −10,483,166 0 owned after | no price filed | 2013-08-01 | |
| 2013-07-30 | Aberdare Ventures III LP | Aberdare GP III, L.L.C. | Aberdare Partners III LP 10% Owner | 10% Owner | 10% Owner | 4 | Series B Preferred Stock Derivative · Indirect · By Aberdare Ventures III, L.P. | C Conversion of derivative security | −5,846,236 0 owned after | no price filed | 2013-08-01 | |
| 2013-07-30 | Aberdare Ventures III LP | Aberdare GP III, L.L.C. | Aberdare Partners III LP 10% Owner | 10% Owner | 10% Owner | 4 | Warrant to Purchase Series A Preferred Stock Derivative · Indirect · By Aberdare Ventures III, L.P. | C Conversion of derivative security | −363,308 0 owned after | $0.01 exercise price | 2013-08-01 | |
| 2013-07-30 | Aberdare Ventures III LP | Aberdare GP III, L.L.C. | Aberdare Partners III LP 10% Owner | 10% Owner | 10% Owner | 4 | Warrant to Purchase Series A Preferred Stock Derivative · Indirect · By Aberdare Ventures III, L.P. | C Conversion of derivative security | −242,205 0 owned after | $0.01 exercise price | 2013-08-01 | |
| 2013-07-30 | Aberdare Ventures III LP | Aberdare GP III, L.L.C. | Aberdare Partners III LP 10% Owner | 10% Owner | 10% Owner | 4 | Series A Preferred Stock Derivative · Indirect · By Aberdare Partners III, L.P. | C Conversion of derivative security | −246,775 0 owned after | no price filed | 2013-08-01 | |
| 2013-07-30 | Aberdare Ventures III LP | Aberdare GP III, L.L.C. | Aberdare Partners III LP 10% Owner | 10% Owner | 10% Owner | 4 | Series B Preferred Stock Derivative · Indirect · By Aberdare Partners III, L.P. | C Conversion of derivative security | −137,626 0 owned after | no price filed | 2013-08-01 | |
| 2013-07-30 | Aberdare Ventures III LP | Aberdare GP III, L.L.C. | Aberdare Partners III LP 10% Owner | 10% Owner | 10% Owner | 4 | Warrant to Purchase Series A Preferred Stock Derivative · Indirect · By Aberdare Partners III, L.P. | C Conversion of derivative security | −8,552 0 owned after | $0.01 exercise price | 2013-08-01 | |
| 2013-07-30 | Aberdare Ventures III LP | Aberdare GP III, L.L.C. | Aberdare Partners III LP 10% Owner | 10% Owner | 10% Owner | 4 | Warrant to Purchase Series A Preferred Stock Derivative · Indirect · By Aberdare Partners III, L.P. | C Conversion of derivative security | −5,701 0 owned after | $0.01 exercise price | 2013-08-01 | |
| 2013-07-30 | Aberdare Ventures III LP | Aberdare GP III, L.L.C. | Aberdare Partners III LP 10% Owner | 10% Owner | 10% Owner | 4 | Warrant to Purchase Series B Preferred Stock Derivative · Indirect · By Aberdare Partners III, L.P. | C Conversion of derivative security | −997 0 owned after | $0.90 exercise price | 2013-08-01 | |
| 2013-07-30 | Perret Marc Olivier Director, 10% Owner | 4 | Series A Preferred Stock Derivative · Indirect · (m) | C Conversion of derivative security | −6,666,668 0 owned after | no price filed | 2013-08-01 | |
| 2013-07-30 | Perret Marc Olivier Director, 10% Owner | 4 | Series B Preferred Stock Derivative · Indirect · (m) | C Conversion of derivative security | −3,717,861 0 owned after | no price filed | 2013-08-01 | |
| 2013-07-30 | Perret Marc Olivier Director, 10% Owner | 4 | Warrants to Purchase Shares of Series A Preferred Stock Derivative · Indirect · (m) | X Exercise of in-the-money or at-the-money derivative security | −385,070 0 owned after | no price filed | 2013-08-01 | |
| 2013-07-30 | Mento Steven J Director, Officer (President, CEO & Director) | 4 | Series A Preferred Stock Derivative · Indirect · See footnote | C Conversion of derivative security | −786,417 0 owned after | no price filed | 2013-08-01 | |
| 2013-07-30 | KLINGENSTEIN PAUL H Director, 10% Owner | 4 | Series A Preferred Stock Derivative · Indirect · (m) | C Conversion of derivative security | −10,483,166 0 owned after | no price filed | 2013-08-01 | |
| 2013-07-30 | KLINGENSTEIN PAUL H Director, 10% Owner | 4 | Series B Preferred Stock Derivative · Indirect · (m) | C Conversion of derivative security | −5,846,236 0 owned after | no price filed | 2013-08-01 | |
| 2013-07-30 | KLINGENSTEIN PAUL H Director, 10% Owner | 4 | Warrant to Purchase Series A Preferred Stock Derivative · Indirect · (m) | C Conversion of derivative security | −363,308 0 owned after | $0.01 exercise price | 2013-08-01 | |
| 2013-07-30 | KLINGENSTEIN PAUL H Director, 10% Owner | 4 | Warrant to Purchase Series A Preferred Stock Derivative · Indirect · (m) | C Conversion of derivative security | −242,205 0 owned after | $0.01 exercise price | 2013-08-01 | |
| 2013-07-30 | KLINGENSTEIN PAUL H Director, 10% Owner | 4 | Series A Preferred Stock Derivative · Indirect · (m) | C Conversion of derivative security | −246,775 0 owned after | no price filed | 2013-08-01 | |
| 2013-07-30 | KLINGENSTEIN PAUL H Director, 10% Owner | 4 | Series B Preferred Stock Derivative · Indirect · (m) | C Conversion of derivative security | −137,626 0 owned after | no price filed | 2013-08-01 | |
| 2013-07-30 | KLINGENSTEIN PAUL H Director, 10% Owner | 4 | Warrant to Purchase Series A Preferred Stock Derivative · Indirect · (m) | C Conversion of derivative security | −8,552 0 owned after | $0.01 exercise price | 2013-08-01 | |
| 2013-07-30 | KLINGENSTEIN PAUL H Director, 10% Owner | 4 | Warrant to Purchase Series A Preferred Stock Derivative · Indirect · (m) | C Conversion of derivative security | −5,701 0 owned after | $0.01 exercise price | 2013-08-01 | |
| 2013-07-30 | KLINGENSTEIN PAUL H Director, 10% Owner | 4 | Warrant to Purchase Series B Preferred Stock Derivative · Indirect · (m) | C Conversion of derivative security | −997 0 owned after | $0.90 exercise price | 2013-08-01 | |
| 2013-07-30 | Malik Shahzad Director, 10% Owner | 4 | Series A Preferred Stock Derivative · Indirect · (m) | C Conversion of derivative security | −10,000,000 0 owned after | no price filed | 2013-08-01 | |
| 2013-07-30 | Malik Shahzad Director, 10% Owner | 4 | Series B Preferred Stock Derivative · Indirect · (m) | C Conversion of derivative security | −5,576,786 0 owned after | no price filed | 2013-08-01 | |
| 2013-07-30 | Malik Shahzad Director, 10% Owner | 4 | Warrants to Purchase Shares of Series A Preferred Stock Derivative · Indirect · (m) | X Exercise of in-the-money or at-the-money derivative security | −577,599 0 owned after | no price filed | 2013-08-01 | |
| 2013-07-30 | LACASSE LOUIS P Director | 4 | Series B Preferred Stock Derivative · Indirect · (m) | C Conversion of derivative security | −5,555,556 0 owned after | no price filed | 2013-08-01 | |
| 2013-07-30 | HALE DAVID F Director | 4 | Series A Preferred Stock Derivative · Indirect · (m) | C Conversion of derivative security | −162,356 0 owned after | no price filed | 2013-08-01 | |
| 2013-07-30 | COOPERATIVE GILDE HEALTHCARE II U.A. 10% Owner | 4 | Series A Preferred Stock Derivative · Direct | C Conversion of derivative security | −6,666,668 0 owned after | no price filed | 2013-08-01 | |
| 2013-07-30 | COOPERATIVE GILDE HEALTHCARE II U.A. 10% Owner | 4 | Series B Preferred Stock Derivative · Direct | C Conversion of derivative security | −3,717,861 0 owned after | no price filed | 2013-08-01 | |
| 2013-07-30 | COOPERATIVE GILDE HEALTHCARE II U.A. 10% Owner | 4 | Warrants to Purchase Shares of Series A Preferred Stock Derivative · Direct | X Exercise of in-the-money or at-the-money derivative security | −385,070 0 owned after | no price filed | 2013-08-01 | |
| 2013-07-30 | Cashion Charles Officer (SVP, Finance, CFO and Sec.) | 4 | Series A Preferred Stock Derivative · Indirect · See footnote | C Conversion of derivative security | −355,352 0 owned after | no price filed | 2013-08-01 | |
| 2013-07-30 | ADVENT VENTURE PARTNERS LLP 10% Owner | 4 | Series A Preferred Stock Derivative · Indirect · See footnotes | C Conversion of derivative security | −10,000,000 0 owned after | no price filed | 2013-08-01 | |
| 2013-07-30 | ADVENT VENTURE PARTNERS LLP 10% Owner | 4 | Series B Preferred Stock Derivative · Indirect · See footnotes | C Conversion of derivative security | −5,576,786 0 owned after | no price filed | 2013-08-01 | |
| 2013-07-30 | ADVENT VENTURE PARTNERS LLP 10% Owner | 4 | Warrants to Purchase Shares of Series A Preferred Stock Derivative · Indirect · See footnotes | X Exercise of in-the-money or at-the-money derivative security | −577,599 0 owned after | no price filed | 2013-08-01 | |
| 2013-07-30 | Scopa James Paul Director | 4 | Series B Convertible Preferred Stock Derivative · Indirect · (m) | C Conversion of derivative security | −8,333,334 0 owned after | $0.00 | 2013-08-01 | |
| 2013-07-30 | Scopa James Paul Director | 4 | Warrant to Purchase Series B Preferred Stock (Right to Buy) Derivative · Indirect · (m) | C Conversion of derivative security | −265,837 0 owned after | $0.90 exercise price | 2013-08-01 | |
| 2013-07-30 | Foley Todd | EVNIN LUKE | KAILIAN VAUGHN M | Vander Vort John | GADICKE ANSBERT 10% Owner | 10% Owner | 10% Owner | 10% Owner | 10% Owner | 4 | Series B Convertible Preferred Stock Derivative · Indirect · See Footnote | C Conversion of derivative security | −8,333,334 0 owned after | $0.00 | 2013-08-01 | |
| 2013-07-30 | Foley Todd | EVNIN LUKE | KAILIAN VAUGHN M | Vander Vort John | GADICKE ANSBERT 10% Owner | 10% Owner | 10% Owner | 10% Owner | 10% Owner | 4 | Warrant to Purchase Series B Preferred Stock (Right to Buy) Derivative · Indirect · See Footnote | C Conversion of derivative security | −265,837 0 owned after | $0.90 exercise price | 2013-08-01 | |
| 2013-07-30 | MPM BioVentures IV LLC | MPM BIOVENTURES V LLC | MPM BioVentures IV GP LLC | MPM BioVentures IV QP LP | MPM ASSET MANAGEMENT INVESTORS BV5 LLC | MPM BIOVENTURES V, L.P. | MPM BioVentures IV GmbH & Co. Beteiligungs KG | MPM BIOVENTURES V GP LLC | MPM Asset Management Investors BV4 LLC 10% Owner | 10% Owner | 10% Owner | 10% Owner | 10% Owner | 10% Owner | 10% Owner | 10% Owner | 10% Owner | 4 | Series B Convertible Preferred Stock Derivative · Indirect · See Footnote | C Conversion of derivative security | −8,333,334 0 owned after | $0.00 | 2013-08-01 | |
| 2013-07-30 | MPM BioVentures IV LLC | MPM BIOVENTURES V LLC | MPM BioVentures IV GP LLC | MPM BioVentures IV QP LP | MPM ASSET MANAGEMENT INVESTORS BV5 LLC | MPM BIOVENTURES V, L.P. | MPM BioVentures IV GmbH & Co. Beteiligungs KG | MPM BIOVENTURES V GP LLC | MPM Asset Management Investors BV4 LLC 10% Owner | 10% Owner | 10% Owner | 10% Owner | 10% Owner | 10% Owner | 10% Owner | 10% Owner | 10% Owner | 4 | Warrant to Purchase Series B Preferred Stock (Right to Buy) Derivative · Indirect · See Footnote | C Conversion of derivative security | −265,837 0 owned after | $0.90 exercise price | 2013-08-01 | |
| 2013-07-24 holding as of filing | Scopa James Paul Director, 10% Owner | 3 | Series B Convertible Preferred Stock Derivative · Indirect · See Footnote | Holding | no price filed | 2013-07-24 | ||
| 2013-07-24 holding as of filing | Scopa James Paul Director, 10% Owner | 3 | Warrant to Purchase Series B Preferred Stock (Right to Buy) Derivative · Indirect · See Footnote | Holding | $0.90 exercise price | 2013-07-24 | ||
| 2013-07-24 holding as of filing | GADICKE ANSBERT | KAILIAN VAUGHN M | Vander Vort John | EVNIN LUKE | Foley Todd 10% Owner | 10% Owner | 10% Owner | 10% Owner | 10% Owner | 3 | Series B Convertible Preferred Stock Derivative · Indirect · See Footnote | Holding | no price filed | 2013-07-24 | ||
| 2013-07-24 holding as of filing | GADICKE ANSBERT | KAILIAN VAUGHN M | Vander Vort John | EVNIN LUKE | Foley Todd 10% Owner | 10% Owner | 10% Owner | 10% Owner | 10% Owner | 3 | Warrant to Purchase Series B Preferred Stock (Right to Buy) Derivative · Indirect · See Footnote | Holding | $0.90 exercise price | 2013-07-24 | ||
| 2013-07-24 holding as of filing | Spada Alfred P. Officer (SVP, R&D and CSO) | 3 | Series A Preferred Stock Derivative · Indirect · (m) | Holding | no price filed | 2013-07-24 | ||
| 2013-07-24 holding as of filing | Perret Marc Olivier Director, 10% Owner | 3 | Series A Preferred Stock Derivative · Indirect · See footnotes | Holding | no price filed | 2013-07-24 | ||
| 2013-07-24 holding as of filing | Perret Marc Olivier Director, 10% Owner | 3 | Series B Preferred Stock Derivative · Indirect · See footnotes | Holding | no price filed | 2013-07-24 | ||
| 2013-07-24 holding as of filing | Perret Marc Olivier Director, 10% Owner | 3 | Warrants to Purchase Shares of Series A Preferred Stock Derivative · Indirect · See footnotes | Holding | $0.01 exercise price | 2013-07-24 | ||
| 2013-07-24 holding as of filing | Perret Marc Olivier Director, 10% Owner | 3 | Warrant to Purchase Shares of Series B Preferred Stock Derivative · Indirect · See footnotes | Holding | $0.90 exercise price | 2013-07-24 | ||
| 2013-07-24 holding as of filing | Mento Steven J Director, Officer (President, CEO & Director) | 3 | Series A Preferred Stock Derivative · Indirect · (m) | Holding | no price filed | 2013-07-24 | ||
| 2013-07-24 holding as of filing | Mento Steven J Director, Officer (President, CEO & Director) | 3 | Warrant to Purchase Shares of Series B Preferred Stock Derivative · Indirect · (m) | Holding | $0.90 exercise price | 2013-07-24 | ||
| 2013-07-24 holding as of filing | Malik Shahzad Director, 10% Owner | 3 | Series A Preferred Stock Derivative · Indirect · See footnotes | Holding | no price filed | 2013-07-24 | ||
| 2013-07-24 holding as of filing | Malik Shahzad Director, 10% Owner | 3 | Series B Preferred Stock Derivative · Indirect · See footnotes | Holding | no price filed | 2013-07-24 | ||
| 2013-07-24 holding as of filing | Malik Shahzad Director, 10% Owner | 3 | Warrants to Purchase Shares of Series A Preferred Derivative · Indirect · See footnotes | Holding | $0.01 exercise price | 2013-07-24 | ||
| 2013-07-24 holding as of filing | Malik Shahzad Director, 10% Owner | 3 | Warrants to Purchase Shares of Series B Preferred Derivative · Indirect · See footnotes | Holding | $0.90 exercise price | 2013-07-24 | ||
| 2013-07-24 holding as of filing | MPM ASSET MANAGEMENT INVESTORS BV5 LLC | MPM BioVentures IV GmbH & Co. Beteiligungs KG | MPM BIOVENTURES V GP LLC | MPM BioVentures IV LLC | MPM BIOVENTURES V, L.P. | MPM Asset Management Investors BV4 LLC | MPM BIOVENTURES V LLC | MPM BioVentures IV GP LLC | MPM BioVentures IV QP LP 10% Owner | 10% Owner | 10% Owner | 10% Owner | 10% Owner | 10% Owner | 10% Owner | 10% Owner | 10% Owner | 3 | Series B Convertible Preferred Stock Derivative · Indirect · See Footnote | Holding | no price filed | 2013-07-24 | ||
| 2013-07-24 holding as of filing | MPM ASSET MANAGEMENT INVESTORS BV5 LLC | MPM BioVentures IV GmbH & Co. Beteiligungs KG | MPM BIOVENTURES V GP LLC | MPM BioVentures IV LLC | MPM BIOVENTURES V, L.P. | MPM Asset Management Investors BV4 LLC | MPM BIOVENTURES V LLC | MPM BioVentures IV GP LLC | MPM BioVentures IV QP LP 10% Owner | 10% Owner | 10% Owner | 10% Owner | 10% Owner | 10% Owner | 10% Owner | 10% Owner | 10% Owner | 3 | Warrant to Purchase Series B Preferred Stock (Right to Buy) Derivative · Indirect · See Footnote | Holding | $0.90 exercise price | 2013-07-24 | ||
| 2013-07-24 holding as of filing | LACASSE LOUIS P Director | 3 | Series B Preferred Stock Derivative · Indirect · See footnote | Holding | no price filed | 2013-07-24 | ||
| 2013-07-24 holding as of filing | LACASSE LOUIS P Director | 3 | Warrant to Purchase Shares of Series B Preferred Stock Derivative · Indirect · See footnote | Holding | $0.90 exercise price | 2013-07-24 | ||
| 2013-07-24 holding as of filing | ADVENT VENTURE PARTNERS LLP 10% Owner | 3 | Series A Preferred Stock Derivative · Indirect · See footnotes | Holding | no price filed | 2013-07-24 | ||
| 2013-07-24 holding as of filing | ADVENT VENTURE PARTNERS LLP 10% Owner | 3 | Series B Preferred Stock Derivative · Indirect · See footnotes | Holding | no price filed | 2013-07-24 | ||
| 2013-07-24 holding as of filing | ADVENT VENTURE PARTNERS LLP 10% Owner | 3 | Warrants to Purchase Shares of Series A Preferred Derivative · Indirect · See footnotes | Holding | $0.01 exercise price | 2013-07-24 | ||
| 2013-07-24 holding as of filing | ADVENT VENTURE PARTNERS LLP 10% Owner | 3 | Warrants to Purchase Shares of Series B Preferred Derivative · Indirect · See footnotes | Holding | $0.90 exercise price | 2013-07-24 | ||
| 2013-07-24 holding as of filing | HALE DAVID F Director | 3 | Series A Preferred Stock Derivative · Indirect · (m) | Holding | no price filed | 2013-07-24 | ||
| 2013-07-24 holding as of filing | HALE DAVID F Director | 3 | Warrant to Purchase Shares of Series B Preferred Stock Derivative · Indirect · (m) | Holding | $0.90 exercise price | 2013-07-24 | ||
| 2013-07-24 holding as of filing | ADVENT VENTURE PARTNERS LLP 10% Owner | 3 | Series A Preferred Stock Derivative · Indirect · See footnotes | Holding | no price filed | 2013-07-24 | ||
| 2013-07-24 holding as of filing | ADVENT VENTURE PARTNERS LLP 10% Owner | 3 | Series B Preferred Stock Derivative · Indirect · See footnotes | Holding | no price filed | 2013-07-24 | ||
| 2013-07-24 holding as of filing | ADVENT VENTURE PARTNERS LLP 10% Owner | 3 | Warrants to Purchase Shares of Series A Preferred Derivative · Indirect · See footnotes | Holding | $0.01 exercise price | 2013-07-24 | ||
| 2013-07-24 holding as of filing | ADVENT VENTURE PARTNERS LLP 10% Owner | 3 | Warrants to Purchase Shares of Series B Preferred Derivative · Indirect · See footnotes | Holding | $0.90 exercise price | 2013-07-24 | ||
| 2013-07-24 holding as of filing | Aberdare GP III, L.L.C. | Aberdare Ventures III LP | Aberdare Partners III LP 10% Owner | 10% Owner | 10% Owner | 3 | Series A Preferred Stock Derivative · Indirect · By Aberdare Ventures III, L.P. | Holding | no price filed | 2013-07-24 | ||
| 2013-07-24 holding as of filing | Aberdare GP III, L.L.C. | Aberdare Ventures III LP | Aberdare Partners III LP 10% Owner | 10% Owner | 10% Owner | 3 | Series A Preferred Stock Derivative · Indirect · By Aberdare Partners III, L.P. | Holding | no price filed | 2013-07-24 | ||
| 2013-07-24 holding as of filing | Aberdare GP III, L.L.C. | Aberdare Ventures III LP | Aberdare Partners III LP 10% Owner | 10% Owner | 10% Owner | 3 | Series B Preferred Stock Derivative · Indirect · By Aberdare Ventures III, L.P. | Holding | no price filed | 2013-07-24 | ||
| 2013-07-24 holding as of filing | Aberdare GP III, L.L.C. | Aberdare Ventures III LP | Aberdare Partners III LP 10% Owner | 10% Owner | 10% Owner | 3 | Series B Preferred Stock Derivative · Indirect · By Aberdare Partners III, L.P. | Holding | no price filed | 2013-07-24 | ||
| 2013-07-24 holding as of filing | Aberdare GP III, L.L.C. | Aberdare Ventures III LP | Aberdare Partners III LP 10% Owner | 10% Owner | 10% Owner | 3 | Warrant to Purchase Series A Preferred Stock Derivative · Indirect · By Aberdare Ventures III, L.P. | Holding | $0.01 exercise price | 2013-07-24 | ||
| 2013-07-24 holding as of filing | Aberdare GP III, L.L.C. | Aberdare Ventures III LP | Aberdare Partners III LP 10% Owner | 10% Owner | 10% Owner | 3 | Warrant to Purchase Series A Preferred Stock Derivative · Indirect · By Aberdare Ventures III, L.P. | Holding | $0.01 exercise price | 2013-07-24 | ||
| 2013-07-24 holding as of filing | Aberdare GP III, L.L.C. | Aberdare Ventures III LP | Aberdare Partners III LP 10% Owner | 10% Owner | 10% Owner | 3 | Warrant to Purchase Series B Preferred Stock Derivative · Indirect · By Aberdare Ventures III, L.P. | Holding | $0.90 exercise price | 2013-07-24 | ||
| 2013-07-24 holding as of filing | Aberdare GP III, L.L.C. | Aberdare Ventures III LP | Aberdare Partners III LP 10% Owner | 10% Owner | 10% Owner | 3 | Warrant to Purchase Series A Preferred Stock Derivative · Indirect · By Aberdare Partners III, L.P. | Holding | $0.01 exercise price | 2013-07-24 | ||
| 2013-07-24 holding as of filing | Aberdare GP III, L.L.C. | Aberdare Ventures III LP | Aberdare Partners III LP 10% Owner | 10% Owner | 10% Owner | 3 | Warrant to Purchase Series A Preferred Stock Derivative · Indirect · By Aberdare Partners III, L.P. | Holding | $0.01 exercise price | 2013-07-24 | ||
| 2013-07-24 holding as of filing | Aberdare GP III, L.L.C. | Aberdare Ventures III LP | Aberdare Partners III LP 10% Owner | 10% Owner | 10% Owner | 3 | Warrant to Purchase Series B Preferred Stock Derivative · Indirect · By Aberdare Partners III, L.P. | Holding | $0.90 exercise price | 2013-07-24 | ||
| 2013-07-24 holding as of filing | COOPERATIVE GILDE HEALTHCARE II U.A. 10% Owner | 3 | Series A Preferred Stock Derivative · Direct | Holding | no price filed | 2013-07-24 | ||
| 2013-07-24 holding as of filing | COOPERATIVE GILDE HEALTHCARE II U.A. 10% Owner | 3 | Series B Preferred Stock Derivative · Direct | Holding | no price filed | 2013-07-24 | ||
| 2013-07-24 holding as of filing | COOPERATIVE GILDE HEALTHCARE II U.A. 10% Owner | 3 | Warrants to Purchase Shares of Series A Preferred Stock Derivative · Direct | Holding | $0.01 exercise price | 2013-07-24 | ||
| 2013-07-24 holding as of filing | COOPERATIVE GILDE HEALTHCARE II U.A. 10% Owner | 3 | Warrant to Purchase Shares of Series B Preferred Stock Derivative · Direct | Holding | $0.90 exercise price | 2013-07-24 | ||
| 2013-07-24 holding as of filing | Cashion Charles Officer (SVP, Finance, CFO and Sec.) | 3 | Series A Preferred Stock Derivative · Indirect · (m) | Holding | no price filed | 2013-07-24 | ||
| 2013-07-24 holding as of filing | KLINGENSTEIN PAUL H Director, 10% Owner | 3 | Series A Preferred Stock Derivative · Indirect · By Aberdare Ventures III, L.P. | Holding | no price filed | 2013-07-24 | ||
| 2013-07-24 holding as of filing | KLINGENSTEIN PAUL H Director, 10% Owner | 3 | Series A Preferred Stock Derivative · Indirect · By Aberdare Partners III, L.P. | Holding | no price filed | 2013-07-24 | ||
| 2013-07-24 holding as of filing | KLINGENSTEIN PAUL H Director, 10% Owner | 3 | Series B Preferred Stock Derivative · Indirect · By Aberdare Ventures III, L.P. | Holding | no price filed | 2013-07-24 | ||
| 2013-07-24 holding as of filing | KLINGENSTEIN PAUL H Director, 10% Owner | 3 | Series B Preferred Stock Derivative · Indirect · By Aberdare Partners III, L.P. | Holding | no price filed | 2013-07-24 | ||
| 2013-07-24 holding as of filing | KLINGENSTEIN PAUL H Director, 10% Owner | 3 | Warrant to Purchase Series A Preferred Stock Derivative · Indirect · By Aberdare Ventures III, L.P. | Holding | $0.01 exercise price | 2013-07-24 | ||
| 2013-07-24 holding as of filing | KLINGENSTEIN PAUL H Director, 10% Owner | 3 | Warrant to Purchase Series A Preferred Stock Derivative · Indirect · By Aberdare Ventures III, L.P. | Holding | $0.01 exercise price | 2013-07-24 | ||
| 2013-07-24 holding as of filing | KLINGENSTEIN PAUL H Director, 10% Owner | 3 | Warrant to Purchase Series B Preferred Stock Derivative · Indirect · By Aberdare Ventures III, L.P. | Holding | $0.90 exercise price | 2013-07-24 | ||
| 2013-07-24 holding as of filing | KLINGENSTEIN PAUL H Director, 10% Owner | 3 | Warrant to Purchase Series A Preferred Stock Derivative · Indirect · By Aberdare Partners III, L.P. | Holding | $0.01 exercise price | 2013-07-24 | ||
| 2013-07-24 holding as of filing | KLINGENSTEIN PAUL H Director, 10% Owner | 3 | Warrant to Purchase Series A Preferred Stock Derivative · Indirect · By Aberdare Partners III, L.P. | Holding | $0.01 exercise price | 2013-07-24 | ||
| 2013-07-24 holding as of filing | KLINGENSTEIN PAUL H Director, 10% Owner | 3 | Warrant to Purchase Series B Preferred Stock Derivative · Indirect · By Aberdare Partners III, L.P. | Holding | $0.90 exercise price | 2013-07-24 |